PubRank

Journal of cancer science & therapy (J Cancer Sci Ther)

Journal PubWeight™ 38.72‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Saracatinib Impairs Head and Neck Squamous Cell Carcinoma Invasion by Disrupting Invadopodia Function. 2009 1.11
2 Correlation of MTDH/AEG-1 and HOTAIR Expression with Metastasis and Response to Treatment in Sarcoma Patients. 2011 1.00
3 TMPRSS2-ERG Fusion Gene Expression in Prostate Tumor Cells and Its Clinical and Biological Significance in Prostate Cancer Progression. 2012 0.97
4 PET/CT and MRI in Bladder Cancer. 2012 0.95
5 Free Base Lysine Increases Survival and Reduces Metastasis in Prostate Cancer Model. 2011 0.94
6 Model-Based Background Correction (MBCB): R Methods and GUI for Illumina Bead-array Data. 2009 0.87
7 History of Cancer, Ancient and Modern Treatment Methods. 2009 0.86
8 In vitro assessment of oxidative stress and apoptotic mechanisms of garlic extract in the treatment of acute promyelocytic leukemia. 2012 0.85
9 Targeting Intracellular Cholesterol is a Novel Therapeutic Strategy for Cancer Treatment. 2014 0.84
10 Evaluating the prognostic significance of FBXW7 expression level in human breast cancer by a meta-analysis of transcriptional profiles. 2012 0.84
11 Activation of Multiple Molecular Mechanisms for Increasing Apoptosis in Human Glioblastoma T98G Xenograft. 2010 0.84
12 Role of Chemokines and Chemokine Receptors in Prostate Cancer Development and Progression. 2010 0.83
13 Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity. 2015 0.82
14 Recent Advances in Targeting Tumor Energy Metabolism with Tumor Acidosis as a Biomarker of Drug Efficacy. 2016 0.81
15 A case report - Volatile metabolomic signature of malignant melanoma using matching skin as a control. 2011 0.81
16 TDP1/TOP1 Ratio as a Promising Indicator for the Response of Small Cell Lung Cancer to Topotecan. 2014 0.81
17 Prostate Cancer Chemoprevention Targeting High Risk Populations: Model for Trial Design and Outcome Measures. 2012 0.81
18 Propolis and its Active Component, Caffeic Acid Phenethyl Ester (CAPE), Modulate Breast Cancer Therapeutic Targets via an Epigenetically Mediated Mechanism of Action. 2013 0.80
19 Doxorubicin Cardiotoxicity and Cardiac Function Improvement After Stem Cell Therapy Diagnosed by Strain Echocardiography. 2013 0.80
20 D-Glucose-Induced Cytotoxic, Genotoxic, and Apoptotic Effects on Human Breast Adenocarcinoma (MCF-7) Cells. 2014 0.80
21 Abnormal Mammary Adipose Tissue Environment of Brca1 Mutant Mice Show a Persistent Deposition of Highly Vascularized Multilocular Adipocytes. 2011 0.79
22 Interventions to Alleviate Symptoms Related to Breast Cancer Treatments and Areas of Needed Research. 2011 0.78
23 Drug Repurposing for Cancer Therapy. 2012 0.78
24 Synthesis and Pharmacological Evolution of Tetrahydroisoquinolines as Anti Breast Cancer Agents. 2014 0.78
25 Characterizing at-Risk Voxels by Using Perfusion Magnetic Resonance Imaging for Cervical Cancer during Radiotherapy. 2012 0.78
26 Regulation of Tumor Angiogenesis and Choroidal Neovascularization by Endogenous Angioinhibitors. 2013 0.78
27 Gap Junction Enhancer Potentiates Cytotoxicity of Cisplatin in Breast Cancer Cells. 2012 0.78
28 Differential Expression of MicroRNAs in Tissues and Plasma Co-exists as a Biomarker for Pancreatic Cancer. 2016 0.78
29 miR-203 Functions as a Tumor Suppressor by Inhibiting Epithelial to Mesenchymal Transition in Ovarian Cancer. 2016 0.77
30 Curcumin Regulates Colon Cancer by Inhibiting P-Glycoprotein in In-situ Cancerous Colon Perfusion Rat Model. 2013 0.77
31 Human Breast Cancer Stem Cells Have Significantly Higher Rate of Clathrin-Independent and Caveolin-Independent Endocytosis than the Differentiated Breast Cancer Cells. 2012 0.77
32 Validation of Different Systems for Tumstatin Expression and its in-vitro and iv-vivo Activities. 2010 0.77
33 EDL-360: A Potential Novel Antiglioma Agent. 2014 0.76
34 Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma. 2015 0.76
35 C-6 Ceramide Induces p53 Dependent Apoptosis in Human Astrocytoma Grade4 (Glioblastoma Multiforme) Cells. 2012 0.76
36 SET domain-containing Protein 4 (SETD4) is a Newly Identified Cytosolic and Nuclear Lysine Methyltransferase involved in Breast Cancer Cell Proliferation. 2013 0.76
37 Evaluation of Arsenic Trioxide Potential for Lung Cancer Treatment: Assessment of Apoptotic Mechanisms and Oxidative Damage. 2015 0.75
38 Development of Novel Anti-Cd20 Monoclonal Antibodies and Modulation in Cd20 Levels on Cell Surface: Looking to Improve Immunotherapy Response. 2015 0.75
39 Distinct Gene Profiles for Tumor and Non-Tumor Tissue in the Head and Neck: An Analytical Approach. 2011 0.75
40 Deciphering the Finger Prints of Brain Cancer Glioblastoma Multiforme from Four Different Patients by Using Near Infrared Raman Spectroscopy. 2015 0.75
41 Metformin and Not Diabetes Influences the Survival of Resected Early Stage NSCLC Patients. 2014 0.75
42 Targeting TRAF3 Downstream Signaling Pathways in B cell Neoplasms. 2015 0.75
43 Knockdown of the Inhibitor of Apoptosis BRUCE Sensitizes Resistant Breast Cancer Cells to Chemotherapeutic Agents. 2015 0.75
44 Anti-VEGFR2 driven nuclear translocation of VEGFR2 and acquired malignant hallmarks are mutation dependent in glioblastoma. 2016 0.75
45 Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant Pathway. 2014 0.75
46 Myxomaviral Anti-Inflammatory Serpin Reduces Myeloid-Derived Suppressor Cells and Human Pancreatic Cancer Cell Growth in Mice. 2013 0.75
47 Comparative Analysis of Differentially Expressed miRNAs and their Downstream mRNAs in Ovarian Cancer and its Associated Endometriosis. 2016 0.75
48 Phase 1 Dose-Escalation Study with LEC/chTNT-3 and Toceranib Phosphate (Palladia(®)) in Dogs with Spontaneous Malignancies. 2015 0.75
49 Arsenic Trioxide Induces Apoptosis via Specific Signaling Pathways in HT-29 Colon Cancer Cells. 2016 0.75
50 A Critical Need for Increased Understanding of the Use of Human Tissues in Biomedical Research. 2012 0.75
Next 50